<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Olson JP</submitter><funding>NIDA NIH HHS</funding><funding>Howard Hughes Medical Institute</funding><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>15948-54</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4097017</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>135(42)</volume><pubmed_abstract>Caged compounds are molecules rendered functionally inert by derivatization with a photochemical protecting group. We describe the design logic behind the development of a diethylaminocoumarin (DEAC) caging chromophore, DEAC450, that absorbs blue light strongly (ε450 = 43,000 M(-1) cm(-1)) and violet light 11-fold more weakly. The absorption minimum is in the wavelength range (340-360 nm) that is traditionally used for photolysis of many widely used nitroaromatic caged compounds (e.g., 4-carboxymethoxy-5,7-dinitroindolinyl(CDNI)-GABA). We used this chromophore to synthesize DEAC450-caged cAMP and found this probe was very stable toward aqueous hydrolysis in the electronic ground state but was photolyzed with a quantum efficiency of 0.78. When DEAC450-cAMP and CDNI-GABA where co-applied to striatal cholinergic interneurons, the caged compounds were photolyzed in an chromatically orthogonal manner using blue and violet light so as to modulate the neuronal firing rate in a bidirectional way.</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Spectral evolution of a photochemical protecting group for orthogonal two-color uncaging with visible light.</pubmed_title><pmcid>PMC4097017</pmcid><funding_grant_id>MH085498</funding_grant_id><funding_grant_id>R01 NS069720</funding_grant_id><funding_grant_id>R01 GM053395</funding_grant_id><funding_grant_id>R01 MH085498</funding_grant_id><funding_grant_id>GM053395</funding_grant_id><funding_grant_id>NS069720</funding_grant_id><funding_grant_id>K99 DA034648</funding_grant_id><pubmed_authors>Sabatini BL</pubmed_authors><pubmed_authors>Banghart MR</pubmed_authors><pubmed_authors>Olson JP</pubmed_authors><pubmed_authors>Ellis-Davies GC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spectral evolution of a photochemical protecting group for orthogonal two-color uncaging with visible light.</name><description>Caged compounds are molecules rendered functionally inert by derivatization with a photochemical protecting group. We describe the design logic behind the development of a diethylaminocoumarin (DEAC) caging chromophore, DEAC450, that absorbs blue light strongly (ε450 = 43,000 M(-1) cm(-1)) and violet light 11-fold more weakly. The absorption minimum is in the wavelength range (340-360 nm) that is traditionally used for photolysis of many widely used nitroaromatic caged compounds (e.g., 4-carboxymethoxy-5,7-dinitroindolinyl(CDNI)-GABA). We used this chromophore to synthesize DEAC450-caged cAMP and found this probe was very stable toward aqueous hydrolysis in the electronic ground state but was photolyzed with a quantum efficiency of 0.78. When DEAC450-cAMP and CDNI-GABA where co-applied to striatal cholinergic interneurons, the caged compounds were photolyzed in an chromatically orthogonal manner using blue and violet light so as to modulate the neuronal firing rate in a bidirectional way.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Oct</publication><modification>2025-04-22T00:58:48.129Z</modification><creation>2019-03-27T01:32:02Z</creation></dates><accession>S-EPMC4097017</accession><cross_references><pubmed>24117060</pubmed><doi>10.1021/ja408225k</doi></cross_references></HashMap>